Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE

(SHP)
SummaryQuotesChartsNewsCalendarCompany 
Business Summary
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows:

- sales of products (95.3%);

- other (4.7%): primarily franchise royalties.

Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Managers
NameAgeSinceTitle
Howard Mayer, Dr.20182018Chief Medical Officer, Senior VP, Head-R&D
Amitabh Singh-2019Director
Susan O'Reilly-2019Secretary & Director
Anthony Denis Ahern-2019Director
Nigel Coffey-2019Director
Paul Keogh-2019Director
Anthony Grannell-2019Director
James Dinniss-2019Director
John Ryan-2019Director
Scott Hunter-2016Senior Director-Global Marketing Ophthalmology
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 925,620,398 892,293,853 96.4% 7,500,000 0.8% 96.4%
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, Nasdaq 100, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  SHP
- Reuters Code :  SHP.L
- Datastream Code :  SHP
Company contact information
Shire
22 Grenville Street
JE4 8PX St. Helier, Jersey, Channel Islands
United Kingdom

Phone : +44 (0)12 56 894 160
Fax : +44
Internet : http://www.shire.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SHIRE0.00%0
JOHNSON & JOHNSON-1.05%337 021
ROCHE HOLDING AG18.49%250 869
MERCK AND COMPANY10.82%216 813
PFIZER-16.47%201 662
NOVARTIS15.95%198 751
NOVO NORDISK AS19.37%123 560
AMGEN4.14%121 571
SANOFI9.44%115 491
ASTRAZENECA15.31%114 358
ABBVIE-17.06%113 045
GLAXOSMITHKLINE10.39%104 864
ELI LILLY AND COMPANY-6.12%99 453
BRISTOL-MYERS SQUIBB COMPANY2.02%86 745
CELGENE CORPORATION60.63%72 965
BAYER AG7.73%67 773
ALLERGAN PLC29.88%56 958
TAKEDA PHARMACEUTICAL COMPANY LIMITED4.42%54 291
JIANGSU HENGRUI MEDICINE CO.62.65%52 406
CHUGAI PHARMACEUTICAL CO., LTD.34.63%41 970
DAIICHI SANKYO COMPANY, LIMITED98.95%40 683